Found: 8
Select item for more details and to access through your institution.
Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology – an analysis of the closed cohorts of a multicentre prospective study.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 843, doi. 10.1038/s41416-024-02789-2
- By:
- Publication type:
- Article
Potential Adverse Outcomes of Shared Decision Making about Palliative Cancer Treatment: A Secondary Analysis of a Randomized Trial.
- Published in:
- Medical Decision Making, 2024, v. 44, n. 1, p. 89, doi. 10.1177/0272989X231208448
- By:
- Publication type:
- Article
Total F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 10, p. 1854, doi. 10.1007/s00259-011-1862-5
- By:
- Publication type:
- Article
Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e578, doi. 10.1634/theoncologist.2019-0453
- By:
- Publication type:
- Article
Everolimus Reduces <sup>89</sup>Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 7, p. 1087, doi. 10.2967/jnumed.113.129056
- By:
- Publication type:
- Article
Localization of an AdrenocorticotropinProducing Pheochromocytoma Using <sup>18</sup>F-Dihydroxyphenylalanine Positron Emission Tomography.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 3, p. 748, doi. 10.1210/jc.2008-2099
- By:
- Publication type:
- Article
Everolimus Induces Rapid Plasma Glucose Normalization in Insulinoma Patients by Effects on Tumor As Well As Normal Tissues.
- Published in:
- Oncologist, 2011, v. 16, n. 6, p. 783, doi. 10.1634/theoncologist.2010-0222
- By:
- Publication type:
- Article
Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics—a prospective multicenter cohort study.
- Published in:
- BMC Medical Genomics, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s12920-022-01343-4
- By:
- Publication type:
- Article